Onward Medical N.V. (ONWD.BR)

EUR 4.23

(0.95%)

Operating Expenses Summary of Onward Medical N.V.

  • Onward Medical N.V.'s latest annual operating expenses in 2023 was 20.64 Million EUR , up 19.05% from previous year.
  • Onward Medical N.V.'s latest quarterly operating expenses in 2024 Q1 was 6.13 Million EUR , up 28.88% from previous quarter.
  • Onward Medical N.V. reported a annual operating expenses of 17.34 Million EUR in annual operating expenses 2022, down -29.18% from previous year.
  • Onward Medical N.V. reported a annual operating expenses of 24.48 Million EUR in annual operating expenses 2021, up 85.44% from previous year.
  • Onward Medical N.V. reported a quarterly operating expenses of 6.13 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • Onward Medical N.V. reported a quarterly operating expenses of 5.55 Million EUR for 2023 Q1, down -68.62% from previous quarter.

Annual Operating Expenses Chart of Onward Medical N.V. (2023 - 2018)

Historical Annual Operating Expenses of Onward Medical N.V. (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 20.64 Million EUR 19.05%
2022 17.34 Million EUR -29.18%
2021 24.48 Million EUR 85.44%
2020 13.2 Million EUR 32.92%
2019 9.93 Million EUR 34.9%
2018 7.36 Million EUR 0.0%

Peer Operating Expenses Comparison of Onward Medical N.V.

Name Operating Expenses Operating Expenses Difference
Nicox S.A. -11.5 Million EUR 279.475%
European Medical Solutions 13.64 Million EUR -51.279%
FERMENTALG 12.34 Million EUR -67.247%
argenx SE 1.34 Billion EUR 98.462%
BioSenic S.A. 7.58 Million EUR -172.254%
Celyad Oncology SA 8.49 Million EUR -143.168%
Hyloris Pharmaceuticals SA 17.98 Million EUR -14.777%
Oxurion NV 12.21 Million EUR -69.027%
PHAXIAM Therapeutics S.A. 24.98 Million EUR 17.374%
Financière de Tubize SA 114.38 Thousand EUR -17948.064%
UCB SA 2.94 Billion EUR 99.298%